New guidelines on caring for ICU patients with COVID-19
- Details
- Category: Development
An international team including McMaster University researchers has come together to issue guidelines for health-care workers treating intensive care unit (ICU) patients with COVID-19. The Surviving Sepsis Campaign COVID-19 panel has released 54 recommendations on such topics as infection control, laboratory diagnosis and specimens, the dynamics of blood flow support, ventilation support, and COVID-19 therapy.
FDA approves first plasma therapy for Houston Methodist COVID-19 patient
- Details
- Category: Development
Houston Methodist received FDA approval Saturday to become the first academic medical center in the nation to transfuse donated plasma from a recovered COVID-19 patient into a critically ill patient. This treatment was fast-tracked to the bedside over the weekend as the death toll in the COVID-19 pandemic soared to more than 2,000 people across the United States, with more than 100,000 Americans sick from the virus.
Favipiravir flu drug 'clearly effective' in treating COVID-19
- Details
- Category: Development
According to the multiple news articles the drug favipiravir (sold under the brand name Avigan), developed by Fujifilm Toyama Chemical, had produced encouraging outcomes in clinical trials in Wuhan and Shenzhen involving 340 patients.
WHO, China leaders discuss next steps in battle against coronavirus outbreak
- Details
- Category: Development
The Director-General of the World Health Organization (WHO), Dr Tedros Adhanom Ghebreyesus, met President Xi Jinping of the People's Republic of China in Beijing. They shared the latest information on the novel coronavirus 2019 (2019-nCoV) outbreak and reiterated their commitment to bring it under control.
Anticancer vaccines gain new lease of life with personalisation techniques
- Details
- Category: Development
Anticancer vaccines have gained a new lease of life with techniques to personalise them to individual patients. Cutting edge developments in this re-energised field were revealed at the ESMO Immuno-Oncology Congress in Geneva, Switzerland. The original anticancer vaccines, launched in the late 1990s, were based on shared tumour antigens and failed to induce a potent immune response.
Economic impact of excess weight now exceeds $1.7 trillion
- Details
- Category: Development
The impact of obesity and overweight on the U.S. economy has eclipsed $1.7 trillion, an amount equivalent to 9.3 percent of the nation's gross domestic product, according to a new Milken Institute report on the role excess weight plays in the prevalence and cost of chronic diseases. The estimate includes $480.7 billion in direct health-care costs and $1.24 trillion in lost productivity, as documented in
World Stroke Day - SVIN latest clinical trials and breaking science news
- Details
- Category: Development
The Society of Vascular and Interventional Neurology (SVIN) would like to announce today on World Stroke Day that it stands committed to the advancement of scientific research to improve the lives of stroke (aka brain-attack) patients worldwide. Stroke and interventional neurologists, who are members of the SVIN, working collaboratively with interventional neuro-radiologists and endovascular
More Pharma News ...
- The Nobel Prize in Physiology or Medicine 2018 was awarded jointly to James P. Allison and Tasuku Honjo "for their discovery of cancer therapy by inhibition of negative immune regulation."
- University of Tokyo's RCAST, Fujitsu, and Kowa successfully create promising new compounds to fight drug-resistant cancer
- Analysis links US government global health R&D funding to jobs, economic benefits across states
- Try exercise to improve memory, thinking
- Nanoparticles as a solution against antibiotic resistance?
- Three of the most deadly cancers get critical funding for research
- The Nobel Prize in Chemistry 2017 - Cool microscope technology revolutionises biochemistry